1. 2019
2. Cyhoeddwyd

   Patient-focused drug development methods for benefit-risk assessments: A case study using discrete choice experiment for antiepileptic drugs

   Holmes, E. A. F., Plumpton, C., Baker, G. A., Jacoby, A., Ring, A., Williamson, P., Marson, A. & Hughes, D. A., Maw 2019, Yn: Clinical Pharmacology and Therapeutics. 105, 3, t. 672-683 12 t.

   Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

3. Cyhoeddwyd

   Attitudes towards epilepsy in the UK population: Results from a 2018 national survey

   Holmes, E., Bourke, S. & Plumpton, C., Chwef 2019, Yn: Seizure: European Journal of Epilepsy. 65, t. 12-19

   Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

4. 2018
5. Cyhoeddwyd

   Societal preferences for funding orphan drugs in the United Kingdom: An application of person trade off and discrete choice experiment methods

   Bourke, S. M., Plumpton, C. & Hughes, D., 9 Mai 2018, Yn: Value in Health. 21, 5, t. 538-546

   Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

6. Cyhoeddwyd

   PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer

   Ghaneh, P., Hanson, R., Titman, A., Lancaster, G., Plumpton, C., Lloyd-Williams, H., Yeo, S. T., Edwards, R., Johnson, C., Abu Hilal, M., Higginson, A., Armstrong, T., Smith, A., Scarsbrook, A., McKay, C., Carter, R., Sutcliffe, R., Bramhall, S., Kocher, H., Cunningham, D., Pereira, S., Davidson, B., Chang, D., Khan, S., Zealley, I., Sarker, D., Al Sarireh, B., Charnley, R., Lobo, D., Nicolson, M., Halloran, C., Raraty, M., Sutton, R., Vinjamuri, S., Evans, J., Campbell, F., Deeks, J., Sanghera, B., Wong, W-L. & Neoptolemos, J., 6 Chwef 2018, Yn: Health Technology Assessment. 22, 7, 148 t.

   Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

7. Cyhoeddwyd

   Rare disease prevention and treatment: The need for a level playing field

   Hughes, D. & Plumpton, C., Chwef 2018, Yn: Pharmacogenomics. 19, 3, t. 243-247

   Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

8. 2017
9. Cyhoeddwyd

   Renal transplant patients’ preference for the supply and delivery of immunosuppressants in Wales: A discrete choice experiment

   Hagemi, A., Plumpton, C. & Hughes, D., 2 Hyd 2017, Yn: BMC Nephrology. 18, 305.

   Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

10. Cyhoeddwyd

    Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout

    Plumpton, C., Alfirevic, A., Pirmohamed, M. & Hughes, D., 1 Hyd 2017, Yn: Rheumatology. 56, 10, t. 1729-1739

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

11. Cyhoeddwyd

    Cost-Effectiveness Of PET/CT In Pre-Operative Staging Of Pancreatic Cancer: An Economic Evaluation Of The PET-PANC Cohort Study

    Plumpton, C., Ghaneh, P., Lloyd-Williams, H., Yeo, S. T. & Edwards, R., Hyd 2017, Yn: Value in Health. 20, 9, t. A589

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl

12. Cyhoeddwyd

    Cost-effectiveness of HLA-B*15:02 screening in Malaysia

    Plumpton, C. & Hughes, D., Hyd 2017, Yn: British Journal of Dermatology. 177, 4, t. 904-905

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Sylw/Dadl

13. Cyhoeddwyd

    Cost-effectiveness of paediatric central venous catheters in the UK: A secondary publication from the CATCH clinical trial

    Ridyard, C., Plumpton, C., Gilbert, R. E. & Hughes, D., 19 Medi 2017, Yn: Frontiers in Pharmacology. 8, 644.

    Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid